Arkolith/Insider Trading/CHRO/Form 4

Francis Knuettel II

CEO, Pres., CFO Treas & SectyChromocell Therapeutics Corp (CHRO) · full profile →Form 4 · filed Jun 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 14, 2024Grant(A)324K——377K
Jun 14, 2024Grant(A)28K——53K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-24-001129) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML